Not applicableUnknownNCT04373928What this trial is testingPersonalized Precision Diagnosis and Treatment of Pancreatic CancerWho this might be right forPancreatic Cancer Changhai Hospital 100
Early research (Phase 1)Ended earlyNCT05432193What this trial is testingFAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)Who this might be right forPancreatic Ductal AdenocarcinomaColorectal CancerEsophageal Cancer+4 more POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company 20
Early research (Phase 1)Active Not RecruitingNCT02595931What this trial is testingM6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forMetastatic Colorectal CarcinomaMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid Neoplasm+15 more National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Looking for participantsNCT06239194What this trial is testingDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsWho this might be right forBiliary Tract CancerBreast CancerCervical Cancer+13 more ModeX Therapeutics, An OPKO Health Company 285
Early research (Phase 1)Active Not RecruitingNCT05919537What this trial is testingStudy of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 MutationWho this might be right forNon-Small Cell Lung CancerPancreatic CancerLocally Advanced Solid Tumor+1 more Hummingbird Bioscience 68
Testing effectiveness (Phase 2)Ended earlyNCT01065805What this trial is testingDemonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or LymphomaWho this might be right forBrain CancerCancerSolid Tumor+1 more AHS Cancer Control Alberta 94
Very early researchStudy completedNCT02153450What this trial is testingStereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic CancerWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more Case Comprehensive Cancer Center 8
Not applicableStudy completedNCT06570174What this trial is testingOral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly PatientsWho this might be right forPancreatic CancerCholangiocarcinomaIntraductal Papillary Mucinous Neoplasm+2 more Yonsei University 60
Not applicableAvailableNCT05974410What this trial is testingExpanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsWho this might be right forGlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more AVM Biotechnology Inc
Large-scale testing (Phase 3)Study completedNCT00425360What this trial is testingGemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Royal Liverpool University Hospital 1,110
Early research (Phase 1)Study completedNCT04299048What this trial is testingStudy to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.Who this might be right forCachexiaNon-Small-Cell Lung CancerPancreatic Cancer+1 more Pfizer 11
Testing effectiveness (Phase 2)Looking for participantsNCT06483555What this trial is testingBasal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxelWho this might be right forPancreatic AdenocarcinomaMetastatic Pancreatic CancerBasal Cell Neoplasm UNC Lineberger Comprehensive Cancer Center 104
Early research (Phase 1)Study completedNCT02639026What this trial is testingTrial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic CancersWho this might be right forMetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more Abramson Cancer Center at Penn Medicine 53
Not applicableLooking for participantsNCT00001276What this trial is testingDiagnosing and Treating Low Blood Sugar LevelsWho this might be right forHypoglycemiaInsulinoma National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 1,500
Testing effectiveness (Phase 2)Study completedNCT00003018What this trial is testingS9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic CancerWho this might be right forPancreatic Cancer SWOG Cancer Research Network 54
Testing effectiveness (Phase 2)Study completedNCT04505553What this trial is testingOral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal CancerWho this might be right forAppendix CarcinomaColon CarcinomaEsophageal Carcinoma+10 more University of Washington 78
Early research (Phase 1)Study completedNCT01643499What this trial is testingGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesWho this might be right forAcinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the GallbladderAdenocarcinoma of Unknown Primary+37 more University of Chicago 79
Not applicableStudy completedNCT02264665What this trial is testingOPALINE : A Study Of Morbidity And Mortality At 2 YearsWho this might be right forPancreatic Neuroendocrine Tumor, Well Differentiated and Progressive Pfizer 144
Early research (Phase 1)Ended earlyNCT03549000What this trial is testingA Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.Who this might be right forNon-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more Novartis Pharmaceuticals 127
Not applicableStudy completedNCT05025371What this trial is testingThe Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic AdenocarcinomaWho this might be right forPancreas Cancer, Duct Cell Adenocarcinoma Iuliu Hatieganu University of Medicine and Pharmacy 312